X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Morepen Laboratories Ltd.
BSE CODE: 500288   |   NSE CODE: MOREPENLAB   |   ISIN CODE : INE083A01026   |   15-May-2024 Hrs IST
BSE NSE
Rs. 46.70
0.32 ( 0.69% )
 
Prev Close ( Rs.)
46.38
Open ( Rs.)
46.85
 
High ( Rs.)
47.64
Low ( Rs.)
46.53
 
Volume
119278
Week Avg.Volume
237470
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 46.70
0.3 ( 0.65% )
 
Prev Close ( Rs.)
46.40
Open ( Rs.)
47.05
 
High ( Rs.)
47.70
Low ( Rs.)
46.50
 
Volume
2258125
Week Avg.Volume
1876338
 
52 WK High-Low Range(Rs.)
25.1
56.4
Source DateBoard Meeting DateDetails
14-May-2024 21-May-2024 Audited Results
19-Feb-2024 22-Feb-2024 Inter alia, consider and approve the following matters: 1. To evaluate proposals for fund raising by the Company, by way of, inter-alia, issue of securities including equity shares or any other equity linked instruments or securities including nonconvertible debt instruments along with warrants and convertible securities other than warrants or any other eligible securities by way of, inter-alia, a preferential allotment or a private placement (including one or more qualified institutions placements or further public issue of equity, in accordance with the applicable provisions of the Companies Act, 2013 and its rules made thereunder and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, or through any other permissible mode, in such manner, and on such terms and conditions as may be deemed appropriate by the Board of Directors, including committee thereof, in its absolute discretion, subject to the receipt of necessary approvals, including the approval of the members of the Company at general meetings or through postal ballot and such other parties including regulatory and statutory approvals as may be required; 2. The notice of Extra-Ordinary General Meeting of the Company or Postal Ballot Notice along with explanatory statement thereto, inter-alia, for seeking approval of the members of the Company in relation to the above fund-raising proposal.
24-Jan-2024 31-Jan-2024 Quarterly Results
26-Oct-2023 02-Nov-2023 Quarterly Results
31-Jul-2023 05-Aug-2023 Quarterly Results
09-May-2023 16-May-2023 Audited Results
06-Feb-2023 13-Feb-2023 Quarterly Results
03-Nov-2022 10-Nov-2022 Quarterly Results
22-Jul-2022 29-Jul-2022 Quarterly Results
28-Apr-2022 05-May-2022 Audited Results
Page 1 of 11
PREV || NEXT